| Literature DB >> 30096957 |
Kateřina Valentová1, Kateřina Purchartová2,3, Lenka Rydlová4,5, Lenka Roubalová6,7, David Biedermann8, Lucie Petrásková9, Alena Křenková10, Helena Pelantová11, Veronika Holečková-Moravcová12, Eva Tesařová13, Josef Cvačka14, Jiří Vrba15,16, Jitka Ulrichová17,18, Vladimír Křen19.
Abstract
Silymarin, an extract from milk thistle (Silybum marianum) fruits, is consumed in various food supplements. The metabolism of silymarin flavonolignans in mammals is complex, the exact structure of their metabolites still remains partly unclear and standards are not commercially available. This work is focused on the preparation of sulfated metabolites of silymarin flavonolignans. Sulfated flavonolignans were prepared using aryl sulfotransferase from Desulfitobacterium hafniense and p-nitrophenyl sulfate as a sulfate donor and characterized by high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR). Their 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and N,N-dimethyl-p-phenylenediamine (DMPD) radical scavenging; ferric (FRAP) and Folin⁻Ciocalteu reagent (FCR) reducing activity; anti-lipoperoxidant potential; and effect on the nuclear erythroid 2-related factor 2 (Nrf2) signaling pathway were examined. Pure silybin A 20-O-sulfate, silybin B 20-O-sulfate, 2,3-dehydrosilybin-20-O-sulfate, 2,3-dehydrosilybin-7,20-di-O-sulfate, silychristin-19-O-sulfate, 2,3-dehydrosilychristin-19-O-sulfate, and silydianin-19-O-sulfate were prepared and fully characterized. Sulfated 2,3-dehydroderivatives were more active in FCR and FRAP assays than the parent compounds, and remaining sulfates were less active chemoprotectants. The sulfated flavonolignans obtained can be now used as authentic standards for in vivo metabolic experiments and for further research on their biological activity.Entities:
Keywords: Silybum marianum; activity; biotransformation; metabolites; sulfate; sulfotransferase
Mesh:
Substances:
Year: 2018 PMID: 30096957 PMCID: PMC6121260 DOI: 10.3390/ijms19082349
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Structures of silymarin flavonolignans used in the study. The structural difference between silybin A and B is shown in blue.
Overview of aryl sulfotransferase from rat liver (AST IV) substrate specificity and isolated sulfated products.
| Substance | Formation of | Isolated Product(s) |
|---|---|---|
| Silybin A/B | + a | Silybin B 20- |
| Silybin A | – c | − c |
| Silybin B | + a | Silybin B 20- |
| Silychristin | + a | – c |
| Silydianin | + a | – c |
a isolated sulfated product(s) and/or release of p-nitrophenol (p-NP), b the case of natural silybin, only silybin B 20-O-sulfate was isolated, c no formation of p-NP and/or isolated sulfated products.
Figure 2Time course of 2,3-dehydrosilybin sulfation by aryl sulfotransferase (AST) from D. hafniense. Both enantiomers were incubated separately with the enzyme and p-nitrophenyl sulfate (p-NPS) as sulfate donor as described in the Experimental. Relative content of the acceptors, i.e., 2,3-dehydrosilybin A (▲) or 2,3-dehydrosilybin B (●) and respective products, i.e., 2,3-dehydrosilybin A 20-O-sulfate (△) or 2,3-dehydrosilybin B 20-O-sulfate (○) were determined from the area under the curve (AUC)% from the respective chromatograms.
Figure 3Time-course of silychristin sulfation by AST from D. hafniense. The reaction mixtures were incubated with the enzyme and p-NPS as sulfate donor separately under Ar (solid line), in low oxygen environment (dashed), and under 100% O2 (dotted line) as described in the Experimental. Relative content of silychristin (△), silychristin-19-O-sulfate (●), and 2,3-dehydrosilychristin-19-O-sulfate (♦) was determined from the AUC% from the respective HPLC chromatograms using the calibration curves of silychristin and 2,3-dehydrosilychristin.
Figure 4Isolated sulfated products. The sulfate groups are highlighted in red.
Isolated flavonolignan sulfates, their purity, analytical characteristics, and yields.
| Compound | Purity [%] * | λmax [nm] † | HRMS-ESI | RT [min] * | Isolated Yield | |
|---|---|---|---|---|---|---|
| [mg/ 100 mg] | [mol%] | |||||
| Silybin A-20- | 99 | 204/285 | 561.07037 | 3.835 | 65.5 | 56 |
| Silybin B 20-O-sulfate | 99.9 | 203/285 | 561.07068 | 3.840 | 46.5 | 40 |
| 2,3-Dehydrosilybin-20- | 95 | 254/368 | 559.05454 | 6.418 | 11 | 10 |
| 2,3-Dehydrosilybin-7,20- | 99 | 255/371 | 639.01115 | 3.439 | 15.5 | 12 |
| Silychristin-19- | 99.5 | 208/288/335 | 561.07092 | 5.422 | 37.5 | 32 |
| 2,3-Dehydrosilychristin-19- | 96 | 256/373 | 559.05526 | 6.756 | 1.1 (54) $ | 0.9.(55) $ |
| Silydianin-19- | ND ‡ | ND ‡ | ND ‡ | ND ‡ | 55 | 58 |
* by HPLC, † by photodiode array (PDA) detector of HPLC, $ by oxidation of silychristin-19-O-sulfate, ‡ not determined (ND) because of the instability of the compound.
Radical scavenging and reducing capacity of flavonolignan sulfates in comparison with non-conjugated flavonolignans.
| Compound | DPPH a IC50 [μM] | ABTS+ b [CE] | FCR c [GAE] | DMPD+ d [CE] | FRAP e [Fe2+] |
|---|---|---|---|---|---|
| Silybin A | 490 ± 21 f | 1.01 ± 0.03 i | 0.33 ± 0.02 k | 0.96 ± 0.01 n | 0.06 ± 0.00 |
| Silybin A 20- | >2500 | 0.02 ± 0.00 | 0.08 ± 0.01 | 0.98 ± 0.01 n | 0.01 ± 0.00 p |
| Silybin B | 546 ± 17 f | 0.97 ± 0.05 i | 0.36 ± 0.03 k | 1.09 ± 0.01 n | 0.04 ± 0.00 q |
| Silybin B 20- | >2500 | 0.04 ± 0.00 | 0.16 ± 0.02 | 0.99 ± 0.01 n | 0.01 ± 0.00 p |
| 2,3-Dehydrosilybin | 13.3 ± 0.6 g | 0.77 ± 0.01 j | 1.51 ± 0.09 l | 1.02 ± 0.02 n | 0.81 ± 0.02 |
| 2,3-Dehydrosilybin-20- | 14.1 ± 0.5 g | 0.71 ± 0.03 j | 1.03 ± 0.01 m | 0.97 ± 0.02 n | 1.46 ± 0.03 r |
| 2,3-Dehydrosilybin-7,20-di- | 106 ± 4 | 0.55 ± 0.03 | 0.95 ± 0.01 m | 1.90 ± 0.10 | 1.61 ± 0.04 |
| Silychristin | 37.1 ± 3.1 | 1.50 ± 0.09 | 1.13 ± 0.23 m | 1.50 ± 0.02o | 0.64 ± 0.06 |
| Silychristin-19- | 587 ± 11 f | 0.62 ± 0.03 k | 0.80 ± 0.11 m | 1.56 ± 0.08o | 0.05 ± 0.01 q |
| 2,3-Dehydrosilychristin | 8.6 ± 0.8 h | 0.93 ± 0.03 l | 1.58 ± 0.04 l | 0.97 ± 0.02 n | 0.28 ± 0.01 |
| 2,3-Dehydro-silychristin-19- | 7.9 ± 0.3 h | 0.62 ± 0.02 n | 1.44 ± 0.01 l | 1.02 ± 0.04 n | 1.44 ± 0.04 r |
| Trolox | 2.9 ± 0.1 | ND | 0.33 ± 0.00 k | ND | ND |
Data are presented as mean ± standard error from at least three independent measurements performed in triplicate. a 1,1-Diphenyl-2-picrylhydrazyl, b 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) cation radical scavenging (vitamin C equivalents), c Folin–Ciocalteau reagent reduction (gallic acid equivalents), d N,N-dimethyl-p-phenylenediamine cation radical scavenging (vitamin C equivalents), e ferric reducing antioxidant power, f–r The values marked with the same letter are not significantly different. ND = not determined.
Anti-lipoperoxidant capacity and lipophilicity of flavonolignan sulfates in comparison with non-conjugated flavonolignans.
| Compound | Lpx a IC50 [μM] | Log | |
|---|---|---|---|
| Exp b | Pred c | ||
| Silybin A | 48.6 ± 0.4 | 1.52 | 1.47 |
| Silybin A 20- | >1000 | −1.65 | −2.03 |
| Silybin B | 68.6 ± 2.2 | 2.17 | 1.47 |
| Silybin B 20- | >1000 | −2.34 | −2.03 |
| 2,3-Dehydrosilybin | 10.4 ± 0.4 | >3 e | 2.44 |
| 2,3-Dehydrosilybin-20- | 13.7 ± 0.4 d | −2.16 | −1.06 |
| 2,3-Dehydrosilybin-7,20-di- | 90.7 ± 3.3 | <−3 f | −1.65 |
| Silychristin | 17.9 ± 0.7 | 1.47 | 1.26 |
| Silychristin-19- | 134 ± 2 | −2.25 | −2.23 |
| 2,3-Dehydrosilychristin | 14.6 ± 0.4 d | >3 e | 2.24 |
| 2,3-Dehydro-silychristin-19- | 12.0 ± 1.8 d | −2.24 | −1.26 |
| Trolox | 32.7 ± 2.4 | ND | 1.63 |
Data are presented as mean ± standard error from at least three independent measurements performed in triplicate. a Inhibition of lipoperoxidation (Lpx) of rat liver microsomal membranes induced by tert-butyl hydroperoxide. b Experimental, c predicted using the Molinspiration property engine. d The values are not significantly different. e,f Concentration of the compound in the aqueous or octanol phase, respectively, was below the quantification limit. ND = not determined.
Figure 5Effect of tested sulfated flavonolignans on NAD(P)/quinone oxidoreductase 1 (NQO1) activity in Hepa1c1c7 cells. Cells were treated for 48 h with 0.1% dimethylsulfoxide (DMSO) (control); 2.5 μM sulforaphane (SFN; positive control); or with indicated concentrations of silybin A 20-O-sulfate (SB A-S), silybin B 20-O-sulfate (SB B-S), 2,3-dehydrosilybin-20-O-sulfate (DHSB-S), 2,3-dehydrosilybin-7,20-di-O-sulfate (DHSB-diS), silychristin-19-O-sulfate (SC-S), or 2,3-dehydrosilychristin-19-O-sulfate (DHSC-S). After treatment, the activity of NQO1 was determined using the NQO1 assay. Data are means ± standard deviation of three experiments. p < 0.05 (*) significantly increased versus control.